Plasma metabonomics study of the patients with acute anterior uveitis based on ultra-performance liquid chromatography–mass spectrometry
- 8 April 2014
- journal article
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 252 (6) , 925-934
Abstract
The identification of the biomarkers of patients with acute anterior uveitis (AAU) may allow for a less invasive and more accurate diagnosis, as well as serving as a predictor in AAU progression and treatment response. The aim of this study was to identify the potential biomarkers and the metabolic pathways from plasma in patients with AAU. Both plasma metabolic biomarkers and metabolic pathways in the AAU patients versus healthy volunteers were investigated using ultra-performance liquid chromatography–mass spectrometry (UPLC–MS) and a metabonomics approach. The principal component analysis (PCA) was used to separate AAU patients from healthy volunteers as well as to identify the different biomarkers between the two groups. Metabolic compounds were matched to the KEGG, METLIN, and HMDB databases, and metabolic pathways associated with AAU were identified. The PCA for UPLC–MS data shows that the metabolites in AAU patients were significantly different from those of healthy volunteers. Of the 4,396 total features detected by UPLC–MS, 102 features were significantly different between AAU patients and healthy volunteers according to the variable importance plot (VIP) values (greater than two) of partial least squares discriminate analysis (PLS-DA). Thirty-three metabolic compounds were identified and were considered as potential biomarkers. Meanwhile, ten metabolic pathways were found that were related to the AAU according to the identified biomarkers. These data suggest that metabolomics study can identify potential metabolites that differ between AAU patients and healthy volunteers. Based on the PCA, PLS-DA, several potential metabolic biomarkers and pathways in AAU patients were found and identified. In addition, the UPLC–MS technique combined with metabonomics could be a suitable systematic biology tool in research in clinical problems in ophthalmology, and can provide further insight into the pathophysiology of AAU.Keywords
This publication has 30 references indexed in Scilit:
- A Preliminary Investigation of NSCL/P Plasma and Urine in Guizhou Province in China Using NMR-Based MetabonomicsThe Cleft Palate Craniofacial Journal, 2013
- Metabolome-Wide Association Study of Neovascular Age-Related Macular DegenerationPLOS ONE, 2013
- Metabonomics Reveals Plasma Metabolic Changes and Inflammatory Marker in Polycystic Ovary Syndrome PatientsJournal of Proteome Research, 2012
- Correlative analysis of neoplasm patients with phlegm-stasis () or abnormal savda () syndrome, based on metabonomicsJournal of Traditional Chinese Medicine, 2012
- The Emerging Field of Quantitative Blood Metabolomics for Biomarker Discovery in Critical IllnessesAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Ultra‐performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studiesJournal of Separation Science, 2011
- Clinical and Epidemiological MetabonomicsBioMed Research International, 2011
- New perspectives on effector mechanisms in uveitisSeminars in Immunopathology, 2008
- Determination of Inosine Monophosphate Dehydrogenase Activity in Human CD4+ Cells Isolated from Whole Blood During Mycophenolic Acid TherapyTherapeutic Drug Monitoring, 2006
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999